Net Loss Per Share of Common Stock - Schedule of Diluted Net Income (Loss) Per Share (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2026	Sep. 30, 2025	Sep. 30, 2026	Sep. 30, 2025
Schedule of Diluted Net Income (Loss) Per Share [Line Items]
Total antidilutive shares	45,993,486	2,878,142	1,063,960,936	2,878,142
Conversion of convertible preferred stock issued and outstanding [Member]
Schedule of Diluted Net Income (Loss) Per Share [Line Items]
Total antidilutive shares		2,644,267	1,017,967,450	2,644,267
Exercise of warrants for common stock [Member]
Schedule of Diluted Net Income (Loss) Per Share [Line Items]
Total antidilutive shares	159,724	159,724	159,724	159,724
Exercise of outstanding stock options [Member]
Schedule of Diluted Net Income (Loss) Per Share [Line Items]
Total antidilutive shares	45,833,762	74,151	45,833,762	74,151